During the recent session, Absci Corp (NASDAQ:ABSI)’s traded shares were 1.36 million, with the beta value of the company hitting 2.12. At the last check today, the stock’s price was $3.19, reflecting an intraday loss of -5.09% or -$0.17. The 52-week high for the ABSI share is $6.72, that puts it down -110.66 from that peak though still a striking 23.2% gain since the share price plummeted to a 52-week low of $2.45. The company’s market capitalization is $366.28M, and the average trade volume was 5.53 million shares over the past three months.
Absci Corp (ABSI) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. ABSI has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.22.
Absci Corp (NASDAQ:ABSI) trade information
Absci Corp (ABSI) registered a -5.09% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -5.09% in intraday trading to $3.19, hitting a weekly high. The stock’s 5-day price performance is -21.06%, and it has moved by -26.69% in 30 days. Based on these gigs, the overall price performance for the year is -44.44%.
The consensus price target of analysts on Wall Street is $6, which implies an increase of 46.83% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $6 and $6 respectively. As a result, ABSI is trading at a discount of -88.09% off the target high and -88.09% off the low.
Absci Corp (ABSI) estimates and forecasts
In the rating firms’ projections, revenue will increase 5.77% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 1.77M as predicted by 8 analyst(s). Meanwhile, a consensus of 3 analyst(s) estimates revenue growth to 4.87M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 338k and 898k respectively. In this case, analysts expect current quarter sales to grow by 423.08% and then jump by 441.95% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -46.78%. While earnings are projected to return 28.03% in 2025, the next five years will return 19.60% per annum.
ABSI Dividends
Absci Corp is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Absci Corp (NASDAQ:ABSI)’s Major holders
The next largest institutional holding, with 8.25 million shares, is of REDMILE GROUP, LLC’s that is approximately 7.3081% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $25.42 million.
Also, the Mutual Funds coming in first place with the largest holdings of Absci Corp (ABSI) shares are ARK ETF Tr-ARK Genomic Revolution ETF and Alger Small Cap Focus Fund. Data provided on Dec 31, 2024 indicates that ARK ETF Tr-ARK Genomic Revolution ETF owns about 7.96 shares. This amounts to just over 6.93 percent of the company’s overall shares, with a $25.32 million market value. The same data shows that the other fund manager holds slightly less at 5.04, or about 4.39% of the stock, which is worth about $16.02 million.
